Based on the Aadi Bioscience Inc stock forecast from 2 analysts, the average analyst target price for Aadi Bioscience Inc is USD 1.63 over the next 12 months. Aadi Bioscience Inc’s average analyst rating is Hold . Stock Target Advisor’s own stock analysis of Aadi Bioscience Inc is Slightly Bearish, which is based on 3 positive signals and 7 negative signals. At the last closing, Aadi Bioscience Inc’s stock price was USD 2.28. Aadi Bioscience Inc’s stock price has changed by +2.70% over the past week, +13.43% over the past month and -52.00% over the last year.
No recent analyst target price found for Aadi Bioscience Inc
No recent average analyst rating found for Aadi Bioscience Inc
Company Overview Aadi Bioscience Inc
Aadi Bioscience, Inc., a biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug product candidate comprises FYARRO, a form of sirolimus protein-bound particles for injectable suspension for the treatment in adult patients with advanced unresectable or metastatic malignant PEComa. The company is also involved in evaluating FYARRO in cancers, including indications targeting specific genomic alterations that activate the mTOR pathway. Aadi Bioscience, Inc. was incorporated in 2007 and is headquartered in Pacific Palisades, California. Address: 17383 Sunset Boulevard, Pacific Palisades, CA, United States, 90272 Read Less
Aadi Bioscience, Inc., a biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug product candidate comprises FYARRO, a form of sirolimus protein-bound particles ...Read More
Frequently Asked Questions About Aadi Bioscience Inc (AADI) Stock
Based on ratings from 2 analysts Aadi Bioscience Inc's stock is Hold . Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has buy, sell and 2 hold ratings.
Unfortunately we do not have enough data on AADI's stock to indicate if its a good dividend stock.
Based on targets from 2 analysts, the average taret price for AADI is USD 1.63 over the next 12 months. The maximum analyst target price is USD 1.75 while the minimum anlayst target price is USD 1.5.
AADI stock's Price/Earning ratio is 1.58.
Our analysis grades AADI stock's Price / Earning ratio at D. This means that AADI stock's Price/Earning ratio is above 36% of the stocks in the Biotechnology sector in the NSD exchange.
Based on this AADI may be fairly valued for its sector
The last closing price of AADI's stock was USD 2.28.
The most recent market capitalization for AADI is USD 0.06B.
Based on targets from 2 analysts, the average taret price for AADI is projected at USD 1.63 over the next 12 months.
This means that AADI's stock price may go down by -28.73% over the next 12 months.
We can't find any ETFs which contains Aadi Bioscience Inc's stock.
As per our most recent records Aadi Bioscience Inc has 53 Employees.
Aadi Bioscience Inc's registered address is 17383 Sunset Boulevard, Pacific Palisades, CA, United States, 90272.
You can get more information about it from Aadi Bioscience Inc's website at https://aadibio.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About Aadi Bioscience Inc (AADI) Stock
Based on ratings from 2 analysts Aadi Bioscience Inc's stock is Hold . Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has buy, sell and 2 hold ratings.
Unfortunately we do not have enough data on AADI's stock to indicate if its a good dividend stock.
Based on targets from 2 analysts, the average taret price for AADI is USD 1.63 over the next 12 months. The maximum analyst target price is USD 1.75 while the minimum anlayst target price is USD 1.5.
AADI stock's Price/Earning ratio is 1.58.
Our analysis grades AADI stock's Price / Earning ratio at D. This means that AADI stock's Price/Earning ratio is above 36% of the stocks in the Biotechnology sector in the NSD exchange.
Based on this AADI may be fairly valued for its sector
The last closing price of AADI's stock was USD 2.28.
The most recent market capitalization for AADI is USD 0.06B.
Based on targets from 2 analysts, the average taret price for AADI is projected at USD 1.63 over the next 12 months.
This means that AADI's stock price may go down by -28.73% over the next 12 months.
We can't find any ETFs which contains Aadi Bioscience Inc's stock.
As per our most recent records Aadi Bioscience Inc has 53 Employees.
Aadi Bioscience Inc's registered address is 17383 Sunset Boulevard, Pacific Palisades, CA, United States, 90272.
You can get more information about it from Aadi Bioscience Inc's website at https://aadibio.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for AADI !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
